Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
McKinsey
Cantor Fitzgerald
Argus Health
Deloitte
Covington
Dow
Healthtrust

Generated: April 25, 2018

DrugPatentWatch Database Preview

CYTOTEC Drug Profile

« Back to Dashboard

Which patents cover Cytotec, and what generic alternatives are available?

Cytotec is a drug marketed by Gd Searle Llc and is included in one NDA.

The generic ingredient in CYTOTEC is misoprostol. There are fourteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the misoprostol profile page.
Drug patent expirations by year for CYTOTEC
Pharmacology for CYTOTEC
Medical Subject Heading (MeSH) Categories for CYTOTEC
Synonyms for CYTOTEC
(+-)-Methyl (1R,2R,3R)-3-hydroxy-2-((E)-(4RS)-4-hydroxy-4-methyl-1-octenyl)-5-oxocyclopentaneheptanoate
(+/-) methyl 11alpha, 16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate
(+/-) methyl 11alpha,16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate
(+/-) methyl-11alpha,16-dihydroxy-16-methyl-9-oxoprost-13E-en-1-oate
(+/-) methyl-11alpha,16-dihydroxy-16-methyl-9-oxoprost13E-en-1-oate
(+/-)-15-Deoxy-(16RS)-16-hydroxy-16-methylprostaglandin E1 methyl ester
(11-alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxoprost-13-en-1-oic acid methyl ester
(11?,13E)-(-)-11,16-Dihydroxy-16-methyl-9-oxo-prost-13-en-1-oic acid methyl ester
(11alpha,13E)-11,16-Dihydroxy-16-methyl-9-oxoprosta-13-ene-1-oic acid methyl ester
103601-27-0
11|A-Misoprostol
122M462
138284-96-5
143913-16-0
59122-46-2
62015-39-8
7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoic acid methyl ester
92999-98-9
A832173
AB00513745-05
AC1NQZZA
AKOS015899652
Ambap103601-27-0
AN-10385
BDBM85606
BRD-A50310035-001-01-6
BRN 4155643
CAS_59122-46-2
CAS-59122-46-2
CCG-221093
CCRIS 6859
CHEBI:94387
CHEMBL606
CS-2828
Cytotec (TN)
D00419
D09ANG
DB00929
DR002173
DSSTox_CID_897
DSSTox_GSID_20897
DSSTox_RID_75852
DTXSID7020897
GTPL1936
GyMiso
HMS2090L10
HMS3648F03
HSDB 3573
HY-B0610
I14-11712
Isprelor
LP097993
Methyl (+-)-11-alpha,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
methyl (11alpha,13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate
methyl 7-((1R,2R,3R)-3-hydroxy-2-((E)-4-hydroxy-4-methyloct-1-en-1-yl)-5-oxocyclopentyl)heptanoate
methyl 7-[(1R,2R,3R)-2-[(E)-4-methyl-4-oxidanyl-oct-1-enyl]-3-oxidanyl-5-oxidanylidene-cyclopentyl]heptanoate
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(1E)-4-hydroxy-4-methyloct-1-en-1-yl]-5-oxocyclopentyl]heptanoate
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyl-oct-1-enyl]-5-oxo-cyclopentyl]heptanoate
methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E)-4-hydroxy-4-methyloct-1-enyl]-5-oxocyclopentyl]heptanoate
MFCD00274550
Misodel
Misogon
Misopess
Misoprost
Misoprostil
misoprostol
MISOPROSTOL (1%) DISPERSION
Misoprostol (JAN/USAN/INN)
misoprostol (methyl ester)
Misoprostol [USAN:USP:INN:BAN:JAN]
Misoprostol for system suitability, European Pharmacopoeia (EP) Reference Standard
Misoprostol, >=99% (HPLC)
Misoprostol, European Pharmacopoeia (EP) Reference Standard
Misoprostol, United States Pharmacopeia (USP) Reference Standard
Misoprostolum
Misoprostolum [INN-Latin]
Misotac
Misotol
MLS000028863
MolPort-003-666-830
MolPort-044-724-057
MVI 200
NCGC00162445-01
NCGC00162445-02
NCGC00162445-03
OJLOPKGSLYJEMD-URPKTTJQSA-N
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-
Prost-13-en-1-oic acid, 11,16-dihydroxy-16-methyl-9-oxo-, methyl ester, (11alpha,13E)-(+-)-
Q-201409
REGID_for_CID_5282381
SC 29333
SC-17968
SC-29333
SCHEMBL7787
SMP1_000193
SMR000058558
SR-01000695425
SR-01000695425-2
SR-01000695425-4
Tox21_112010
XP-16J

US Patents and Regulatory Information for CYTOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CYTOTEC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-003 Sep 21, 1990 ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc CYTOTEC misoprostol TABLET;ORAL 019268-001 Dec 27, 1988 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Cerilliant
Farmers Insurance
AstraZeneca
Argus Health
Queensland Health
Citi
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.